$NUVB

Nuvation Bio Inc.

NYSE · Healthcare · Pharmaceutical Preparations · New York, NY

NUVB chart

What traders are saying about $NUVB

Latest posts

Nuvation Bio Inc. news

Nuvation Bio Inc. key financials

USD2025202420232022
Revenue$62.9M$7.9M$0–
Net income-$204.6M-$567.9M-$75.8M-$104.2M
Diluted EPS$-0.60$-2.11$-0.35$-0.48
Total assets (year end)$594.8M$540.6M$621.5M$672.1M
Cash and equivalents (year end)$164.1M$35.7M$42.6M$101.1M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Nuvation Bio Inc.

Ticker
NUVB (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1811063
Former names
Panacea Acquisition Corp

Frequently asked questions

What exchange is Nuvation Bio Inc. listed on?

Nuvation Bio Inc. trades on the NYSE under the ticker symbol NUVB.

What industry is Nuvation Bio Inc. in?

Nuvation Bio Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Nuvation Bio Inc. headquartered?

Nuvation Bio Inc.'s business address on file with the SEC is in New York, NY.

When does Nuvation Bio Inc.'s fiscal year end?

Nuvation Bio Inc.'s fiscal year ends on December 31.

How much revenue did Nuvation Bio Inc. report?

Nuvation Bio Inc. reported $62.9M in revenue for calendar year 2025, according to its SEC filings.